[Carpipramine in child psychiatry].
The use of Carpipramine in 35 children and teenagers, most of them suffering from psychosis, has confirmed its beneficient action in the majority of those cases (5 negative scores for 20 good and very good scores). The early-observed improvement concerned inhibition, lack of energy, moroseness, favouring the patients' integration in the institutional context.
D000293:Adolescent; D001321:Autistic Disorder / Q000188:drug therapy; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D003863:Depression / Q000188:drug therapy; D003984:Dibenzazepines / Q000627:therapeutic use*; D006801:Humans; D006948:Hyperkinesis / Q000188:drug therapy; D009497:Neurotic Disorders / Q000188:drug therapy; D011618:Psychotic Disorders / Q000188:drug therapy*
D003984:Dibenzazepines
La carpipramine en pédopsychiatrie.